Advances in the management of endometriosis: an update for clinicians
The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Abstract
Endometriosis is a chronic and recurrent disease characterized by the presence and proliferation of endometrial tissue outside the uterine cavity, which occurs in approximately 10% of women of reproductive age. In this estrogen-dependent disorder, lesions become inactive and gradually undergo regression during states of ovarian down-regulation, such as amenorrhoea or menopause. The impact of endometriosis includes impaired fertility potential, as well as symptoms of dysmenorrhoea, dyspareunia and chronic non-menstrual pain, all of which adversely affect quality of life. Management of endometriosis focuses on pain relief and includes medical and surgical treatment. Pharmacologic therapies currently in use include combination oral contraceptives (COCs), danazol, GnRH analogues and progestins. Although some agents show efficacy in relieving pain, all differ in their side effects, making it difficult to achieve a balance between efficacy and safety. Efficacy has been demonstrated with danazol or GnRH analogues; however, treatment is limited to 6 months because of significant metabolic side effects. Alternatives for longer-term management of symptoms include add-back therapy with GnRH analogues, COCs or progestins. Newer options for treatment of endometriosis include depot medroxyprogesterone acetate subcutaneous injection, as well as several agents under investigation that may prove to have therapeutic potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Levonorgestrel (LNG) has also been used for treating women with symptomatic minimal-to-moderate endometriosis [10], leading to improvements in the severity and frequency of pain and menstrual symptoms.”
From Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment (2012) · cites this paper as [10]
Citations
Cites
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 1×
“…can be difficult, given the non-specific nature of many of its symptoms, the common occurrence of pelvic pain in women without endometriosis and the considerable overlap with other conditions (e.g. pelvic inflammatory disease or irritable bowel syndrome) (Child et al., 2001; Kennedy et al., 2005).”
BackgroundSelf-citationSelective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Effect of endometriosis on in vitro fertilization
Barnhart, K., Dunsmoor-Su, R., & Coutifaris, C. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03112-6 · Cited by 794
Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial
Abbott, J., Hawe, J., Hunter, D., Holmes, M., Finn, P., & Garry, R. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.046 · Cited by 502 · cited 5×
“Nevertheless, surgery is an invasive therapeutic option that is far from ideal, because 20% of cases do not respond (Abbott et al., 2004), and the recurrence rate is high after surgery (Milingos et al.”
BackgroundInfluentialPeritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis
Gazvani, R., & Templeton, A. (2002) · Reproduction · doi:10.1530/rep.0.1230217 · Cited by 394
Endometriosis and Subfertility: Is the Relationship Resolved?
(2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-41330 · Cited by 321
Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation
Rosenberg, M. J., Waugh, M. S., & Meehan, T. E. (1995) · Contraception · doi:10.1016/0010-7824(95)00074-k · Cited by 317
Research works printed but not linked: 19
- Berenson, 2001, Obstet Gynecol, 98, 576
- Chang, 1996, Chin Med J (Taipei), 57, 431
- Cheewadhanaraks, 2004, J Med Assoc Thai, 87, 740
- Crosignani, 1992, Clin Ther, 14, 29
- Crosignani, 2005, Hum Reprod
- Cundy, 1998, Obstet Gynecol, 92, 569
- Filicori, 1993, J Clin Endocrinol Metab, 77, 130
- Gianetto-Berrutti, 2003, Minerva Ginecol, 55, 407
- Henzl, 2003, J Reprod Med, 48, 525
- Luciano, 1988, Obstet Gynecol, 72, 323
- Marques, 2004, J Reprod Med, 49, 115
- Nelson, 2002, J Reprod Med, 47, 781
- Olive, 1987, Obstet Gynecol, 69, 412
- Regidor, 2001, Gynecol Endocrinol, 15, 202, 10.1080/gye.15.3.202.209 · doi:10.1080/gye.15.3.202.209 · Paper page
- Rotondi, 2002, Eur J Gynaecol Oncol, 23, 523
- Saito, 2003, Arzneimittelforschung/Drug Res, 53, 507
- Schlaff, Fertil Steril.
- Viganò, 2003, Curr Opin Investig Drugs, 4, 1209
- Winkel, 2003, Obstet Gynecol, 102, 397
Cited by
Dysmenorrhea and related disorders
Bernardi, M., Lazzeri, L., Perelli, F., Reis, F. M., & Petraglia, F. (2017) · F1000Research · doi:10.12688/f1000research.11682.1 · Cited by 367
Janssen, E. B., Rijkers, A. C. M., Hoppenbrouwers, K., Meuleman, C., & D'Hooghe, T. M. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt016 · Cited by 318
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
“Combination with add-back therapy may extend the period for which GnRH agonists can be used, although long-term safety data on this treatment regimen are limited (3).”
BackgroundHarada, T., Momoeda, M., Taketani, Y., Hoshiai, H., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.051 · Cited by 289
Harada, T., Momoeda, M., Taketani, Y., Aso, T., Fukunaga, M., Hagino, H., & Terakawa, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.080 · Cited by 279
Khan, K. N., Kitajima, M., Hiraki, K., Fujishita, A., Sekine, I., Ishimaru, T., & Masuzaki, H. (2010) · Human Reproduction · doi:10.1093/humrep/dep437 · Cited by 268
Seracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Montanari, G., Keramyda, A., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.052 · Cited by 228
Therapeutic options for management of endometrial hyperplasia
Chandra, V., Kim, J. J., Benbrook, D. M., Dwivedi, A., & Rai, R. (2016) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e8 · Cited by 223
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Oral contraceptives for pain associated with endometriosis
Brown, J., Crawford, T. J., Datta, S., & Prentice, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001019.pub3 · Cited by 199
As-Sanie, S., Kim, J., Schmidt-Wilcke, T., Sundgren, P. C., Clauw, D. J., Napadow, V., & Harris, R. E. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2015.09.008 · Cited by 199
Long‐term use of dienogest for the treatment of endometriosis
Momoeda, M., Harada, T., Terakawa, N., Aso, T., Fukunaga, M., Hagino, H., & Taketani, Y. (2009) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2009.01076.x · Cited by 192
Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways
Patel, B. G., Lenk, E. E., Lebovic, D. I., Shu, Y., Yu, J., & Taylor, R. N. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.006 · Cited by 191
Bouchard, P., Chabbert-Buffet, N., & Fauser, B. C. J. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.021 · Cited by 184
Endometriosis: Current Therapies and New Pharmacological Developments
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Barbara, G., & Crosignani, P. G. (2009) · Drugs · doi:10.2165/00003495-200969060-00002 · Cited by 182
Self-citation“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180
“…the disease (D’Hooghe, 2003; Nothnick and D’Hooghe, 2003; Fedele and Berlanda, 2004; Olive et al., 2004; Attar and Bulun, 2006; Chlouber et al., 2006; Crosignani et al., 2006a; Mihalyi et al., 2006; Hompes and Mijatovic, 2007; Fedele et al., 2008; Guo, 2008; Panay, 2008; Ferrero et al., 2010a) and…”
BackgroundSelf-citationSasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177
Dienogest in the treatment of endometriosis: systematic review
Andres, M. D. P., Lopes, L. A., Baracat, E. C., & Podgaec, S. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3681-6 · Cited by 167
Seracchioli, R., Mabrouk, M., Manuzzi, L., Vicenzi, C., Frasca, C., Elmakky, A., & Venturoli, S. (2009) · Human Reproduction · doi:10.1093/humrep/dep259 · Cited by 158
Seracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Savelli, L., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.083 · Cited by 158
Harel, Z. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.725045 · Cited by 155
“%) of adolescents reported less dysmenorrhea symptoms while using DMPA (Depo-Provera ) as a contraceptive method [70].”
BackgroundInfluentialProstaglandin E 2 : the master of endometriosis?
Wu, M.-H., Lu, C.-W., Chuang, P.-C., & Tsai, S.-J. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009321 · Cited by 134
Endometriosis: current and future medical therapies
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Daguati, R., & Crosignani, P. G. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.10.001 · Cited by 152
Self-citationWalch, K., Unfried, G., Huber, J., Kurz, C., van Trotsenburg, M., Pernicka, E., & Wenzl, R. (2009) · Contraception · doi:10.1016/j.contraception.2008.07.017 · Cited by 128
Li, T., Mamillapalli, R., Ding, S., Chang, H., Liu, Z.-W., Gao, X.-B., & Taylor, H. S. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy035 · Cited by 113
Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway
Duffy, D. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv026 · Cited by 121
Neuroendocrine–immune disequilibrium and endometriosis: an interdisciplinary approach
Tariverdian, N., Theoharides, T. C., Siedentopf, F., Gutiérrez, G., Jeschke, U., Rabinovich, G. A., Blois, S. M., & Arck, P. C. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0077-0 · Cited by 120
“Importantly, progestins are known to be effective in the control of pain symptoms in general or related to endometriosis [112, 116, 117].”
BackgroundNatural therapies assessment for the treatment of endometriosis
Ricci, A. G., Olivares, C. N., Bilotas, M. A., Bastón, J. I., Singla, J. J., Meresman, G. F., & Barañao, R. I. (2012) · Human Reproduction · doi:10.1093/humrep/des369 · Cited by 119
Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen
Coffee, A. L., Sulak, P. J., & Kuehl, T. J. (2007) · Contraception · doi:10.1016/j.contraception.2007.01.014 · Cited by 113
Endometriosis: disease pathophysiology and the role of prostaglandins
Wu, M.-H., Shoji, Y., Chuang, P.-C., & Tsai, S.-J. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940700021x · Cited by 108
Intraperitoneal immune cell status in infertile women with and without endometriosis
Tariverdian, N., Siedentopf, F., Rücke, M., Blois, S. M., Klapp, B. F., Kentenich, H., & Arck, P. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.12.005 · Cited by 112
Walters, K. A., McTavish, K. J., Seneviratne, M. G., Jimenez, M., McMahon, A. C., Allan, C. M., Salamonsen, L. A., & Handelsman, D. J. (2009) · Endocrinology · doi:10.1210/en.2008-1750 · Cited by 99
Ebert, A. D., Dong, L., Merz, M., Kirsch, B., Francuski, M., Böttcher, B., Roman, H., Suvitie, P., Hlavackova, O., Gude, K., et al. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.01.014 · Cited by 97
Elizur, S. E., Chian, R., Holzer, H. E. G., Gidoni, Y., Tulandi, T., & Tan, S. L. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.040 · Cited by 97
Medical Treatments for Endometriosis-Associated Pelvic Pain
Zito, G., Luppi, S., Giolo, E., Martinelli, M., Venturin, I., Di Lorenzo, G., & Ricci, G. (2014) · BioMed Research International · doi:10.1155/2014/191967 · Cited by 93
Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis
Harada, T., & Taniguchi, F. (2010) · Women's Health · doi:10.2217/whe.09.72 · Cited by 92
Endometriosis and Chronic Pelvic Pain: Unraveling the Mystery Behind this Complex Condition
Bloski, T. G., & Pierson, R. A. (2008) · Nursing for Women s Health · doi:10.1111/j.1751-486x.2008.00362.x · Cited by 110
Sakr, S., Naqvi, H., Komm, B., & Taylor, H. S. (2014) · Endocrinology · doi:10.1210/en.2013-1977 · Cited by 91
The role of prostaglandin E 2 in endometriosis
Sacco, K., Portelli, M., Pollacco, J., Schembri-Wismayer, P., & Calleja-Agius, J. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.588753 · Cited by 85
Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis
Abbas, M. A., Taha, M. O., Disi, A. M., & Shomaf, M. S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.016 · Cited by 90
Activated AKT Pathway Promotes Establishment of Endometriosis
Kim, T. H., Yu, Y., Luo, L., Lydon, J. P., Jeong, J., & Kim, J. J. (2014) · Endocrinology · doi:10.1210/en.2013-1951 · Cited by 88
Bernuit, D., Ebert, A. D., Halis, G., Strothmann, A., Gerlinger, C., Geppert, K., & Faustmann, T. (2011) · Journal of Endometriosis · doi:10.5301/je.2011.8525 · Cited by 83
Dysmenorrhea and endometriosis in young women.
(2013) · Europe PMC (PubMed Central) · Cited by 82
Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature
Selçuk, İ., & Bozdağ, G. (2013) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2013.52385 · Cited by 87
Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis
Rowlands, I. J., Teede, H., Lucke, J., Dobson, A. J., & Mishra, G. D. (2016) · Human Reproduction · doi:10.1093/humrep/dew174 · Cited by 70
Safety of medical treatments for endometriosis
Berlanda, N., Somigliana, E., Viganò, P., & Vercellini, P. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1121991 · Cited by 78
Evolution of medical treatment for endometriosis: back to the roots?
Wieser, F., Cohen, M., Gaeddert, A., Yu, J., Burks-Wicks, C., Berga, S. L., & Taylor, R. N. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm015 · Cited by 76
Treatment strategies for endometriosis
Rodgers, A. K., & Falcone, T. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.243 · Cited by 73
Shimizu, Y., Mita, S., Takeuchi, T., Notsu, T., Mizuguchi, K., & Kyo, S. (2010) · Steroids · doi:10.1016/j.steroids.2010.08.010 · Cited by 79
Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function
Du, Y., Zhang, Z., Xiong, W., Li, N., Liu, H., He, H., Li, Q., Liu, Y., & Zhang, L. (2019) · Reproduction · doi:10.1530/rep-18-0424 · Cited by 76
Sansone, A., Rosa, N. D., Giampaolino, P., Guida, M., Laganà, A. S., & Carlo, C. D. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4851-0 · Cited by 74
Vincent, K. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.073494 · Cited by 73
Itoh, H., Uchida, M., Sashihara, T., Ji, Z., Li, J., Tang, Q., Shuang, N., Song, L., & Kaminogawa, S. (2010) · Cytotechnology · doi:10.1007/s10616-010-9326-5 · Cited by 76
Zhang, L., Xiong, W., Xiong, Y., Liu, H., & Liu, Y. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw025 · Cited by 78
Eaton, J. L., Unno, K., Caraveo, M., Lu, Z., & Kim, J. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1661 · Cited by 67
Shimizu, Y., Takeuchi, T., Mita, S., Mizuguchi, K., Kiyono, T., Inoue, M., & Kyo, S. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap042 · Cited by 69
The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis
Olivares, C., Ricci, A., Bilotas, M., Barañao, R. I., & Meresman, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.063 · Cited by 65
Oral contraceptives for pain associated with endometriosis
Davis, L.-J., Kennedy, S. S., Moore, J., & Prentice, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001019.pub2 · Cited by 65
Taha, L. E., Musa, A. A., Khalifeh, D., Khalil, A., Abbasi, S. A., & Nassif, J. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.10.029 · Cited by 73
Razzi, S., Luisi, S., Ferretti, C., Calonaci, F., Gabbanini, M., Mazzini, M., & Petraglia, F. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.08.002 · Cited by 62
Chwalisz, K., Surrey, E., & Stanczyk, F. Z. (2012) · Reproductive Sciences · doi:10.1177/1933719112438061 · Cited by 58
Maytham, G. D., Dowson, H. M., Levy, B., Kent, A., & Rockall, T. A. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.01993.x · Cited by 55
Endometriosis: The way forward
Hompes, P. G. A., & Mijatovic, V. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601010474 · Cited by 55
Wu, B., Yang, Z., Tobe, R., & Wang, Y. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14786 · Cited by 59
Harada, T., Momoeda, M., Terakawa, N., Taketani, Y., & Hoshiai, H. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.045 · Cited by 58
Morelli, M., Sacchinelli, A., Venturella, R., Mocciaro, R., & Zullo, F. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12030 · Cited by 52
Cho, S., Ahn, Y. S., Choi, Y. S., Seo, S. K., Nam, A., Kim, H. Y., Kim, J., Park, K. H., Cho, D. J., & Lee, B. S. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00692.x · Cited by 51
Samy, A., Taher, A. M., Sileem, S., Abdelhakim, A. M., Fathi, M. M., Haggag, H. M., Ashour, K., Ahmed, S. A., Shareef, M. A., AlAmodi, A. A., et al. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101798 · Cited by 56
Delbandi, A., Mahmoudi, M., Shervin, A., & Zarnani, A. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12463 · Cited by 54
Ohama, Y., Harada, T., Iwabe, T., Taniguchi, F., Takenaka, Y., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.061 · Cited by 50
Peroxisome Proliferator‐Activated Receptors: New Players in the Field of Reproduction
Tóth, B., Hornung, D., Scholz, C., Djalali, S., Friese, K., & Jeschke, U. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00514.x · Cited by 53
Drug delivery for the treatment of endometriosis and uterine fibroids
Friend, D. R. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0423-2 · Cited by 49
Balen, A. H. (2008) · CRC Press eBooks · doi:10.3109/9781439807224 · Cited by 49
Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis
Mabrouk, M., Frascà, C., Geraci, E., Montanari, G., Ferrini, G., Raimondo, D., Alvisi, S., Paradisi, R., Villa, G., & Seracchioli, R. (2011) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2011.04.008 · Cited by 51
Fang, R.-C., Tsai, Y., Lai, J., Yeh, C.-H., & Wu, C. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/591391 · Cited by 46
Agostinis, C., Zorzet, S., Leo, R. D., Zauli, G., Seta, F. D., & Bulla, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/918089 · Cited by 48
Liu, Y., Gong, H., Gou, J., Liu, X., & Li, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.652505 · Cited by 47
Mita, S., Shimizu, Y., Sato, A., Notsu, T., Imada, K., & Kyo, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.038 · Cited by 50
Erten, Ö., Ensarı, T. A., Dilbaz, B., Çakıroğlu, H., Altınbaş, Ş. K., Çaydere, M., & Göktolga, Ü. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2015.07.004 · Cited by 47
Lin, S., Lee, H., Hou, P., Fu, J., Wu, M., & Tsai, S. (2017) · The Journal of Pathology · doi:10.1002/path.4922 · Cited by 40
Al‐Jefout, M., & Nawaiseh, N. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.08.009 · Cited by 45
A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
Soysal, D., Kızıldağ, S., Saatli, B., Posacı, C., Soysal, S., Koyuncuoğlu, M., & Doğan, E. (2014) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2014-0077 · Cited by 42
Ichioka, M., Mita, S., Shimizu, Y., Imada, K., Kiyono, T., Bono, Y., & Kyo, S. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.12.008 · Cited by 42
Pazhohan, A., Amidi, F., Akbari-Asbagh, F., Seyedrezazadeh, E., Farzadi, L., Khodarahmin, M., Mehdinejadiani, S., & Sobhani, A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.10.025 · Cited by 43
Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis
İlhan, M., Dereli, F. T. G., & Akkol, E. K. (2018) · Current Drug Delivery · doi:10.2174/1567201816666181227112421 · Cited by 43
Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis
Cho, S., Choi, Y. S., Jeon, Y. E., Im, K. J., Choi, Y., Yim, S. Y., Kim, H., Seo, S. K., & Lee, B. S. (2012) · Microvascular Research · doi:10.1016/j.mvr.2011.12.004 · Cited by 41
Taniguchi, F., Enatsu, A., Ota, I., Toda, T., Arata, K., & Harada, T. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.006 · Cited by 39
Effects ofLactobacillus gasseriOLL2809 on the Induced Endometriosis in Rats
Uchida, M., & Kobayashi, O. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.130319 · Cited by 37
Rakhila, H., Carli, C., Daris, M., Lemyre, M., Lebœuf, M., & Akoum, A. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.016 · Cited by 44
Targeting Mast Cells in Endometriosis with Janus Kinase 3 Inhibitor, JANEX‐1
D’Cruz, O. J., & Uckun, F. M. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00502.x · Cited by 39
Wang, H., Zhao, X., Ni, C., Dai, Y., & Guo, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8823 · Cited by 35
RetractedNiekerk, L. M. V., Steains, E., & Matthewson, M. L. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110993 · Cited by 34
Gonçalves, G. A., Camargo-Kosugi, C. M., Bonetti, T. C., Invitti, A. L., Girão, M. J. B. C., Silva, I. D. C. G., & Schor, E. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1079-8 · Cited by 34
Targeting galectin‐1‐induced angiogenesis mitigates the severity of endometriosis
Bastón, J. I., Barañao, R. I., Ricci, A. G., Bilotas, M. A., Olivares, C. N., Singla, J. J., González, A. M., Stupirski, J. C., Croci, D. O., Rabinovich, G. A., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4397 · Cited by 33
Mabrouk, M., Solfrini, S., Frascà, C., Forno, S. D., Montanari, G., Ferrini, G., Paradisi, R., & Seracchioli, R. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.634936 · Cited by 33
Schultze-Mosgau, M.-H., Waellnitz, K., Nave, R., Klein, S., Kraetzschmar, J., Rautenberg, T., Schmitz, H., & Rohde, B. (2016) · Human Reproduction · doi:10.1093/humrep/dew145 · Cited by 31
Ozaki, R., Kumakiri, J., Jinushi, M., Ikuma, S., Murakami, K., Kawasaki, Y., & Kitade, M. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05691-3 · Cited by 33
Pinot-Monange, A., Moisset, X., Chauvet, P., Grémeau, A., Comptour, A., Canis, M. J., Pereira, B., & Bourdel, N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040508 · Cited by 33
Endometriose intestinal: uma doença benigna?
Bassi, M. A., Podgaec, S., Júnior, J. A. D. D., Sobrado, C. W., Filho, N. D., & Abrão, M. S. (2009) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302009000500029 · Cited by 46
Mitochondria DNA Polymorphisms Are Associated with Susceptibility to Endometriosis
Cho, S., Lee, Y., Choi, Y. S., Yang, H. I., Jeon, Y. E., Lee, K. E., Lim, K. J., Kim, H. Y., Seo, S. K., & Lee, B. S. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1279 · Cited by 32
Metadata
- Authors
- Crosignani, P., Olive, D., Bergqvist, A., & Luciano, A.
- Affiliations
- University of Milan (IT)
- Karolinska Institutet (SE)
- University of Connecticut (US)
- Corresponding author
- Crosignani, PierGiorgio
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-09
- Volume
- 12
- Issue
- 2
- Pages
- 179-189
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2141979474
- Cited by
- 237
- References
- 94
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 17 · 2016: 10 · 2015: 16 · 2014: 17 · 2013: 15 · 2012: 14
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, endometriosis treatment, medical therapy, surgical treatment, combined oral contraceptives, danazol, GnRH analogues, progestins, add-back therapy, depot medroxyprogesterone acetate, fertility preservation, dysmenorrhea, chronic pelvic pain, quality of life, treatment side effects
- MeSH terms
- Contraceptives, Oral, Combined, Danazol, Endometriosis, Female, Hormones, Humans, Gonadotropin-Releasing Hormone, Progestins, Quality of Life, Receptors, Progesterone, Estrogen Receptor Modulators, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.